Tetrabutylphosphonium bis(trifluoromethyl sulfonyl)imide

We are Tetrabutylphosphonium bis(trifluoromethyl sulfonyl)imide CAS:C18H36F6NO4PS2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


English Name: Tetrabutylphosphonium bis(trifluoromethyl sulfonyl)imide
Synonyms:Tetrabutylphosphonium bis(trifluoromethyl sulfonyl)imide
Molecular Formula: C18H36F6NO4PS2
Molecular Weight: 539.58
CAS No.: C18H36F6NO4PS2
Purity: 99%
 
Technical Information

Appearance: Purity:
NMR: Passed null
Solubility: Insolubility:
Impurity content:
(1) Halogen content: < 1000 ppm;
(2) Water content: < 1000 ppm

 
Physics-Chemistry Properties

Melting point: 65°C (Tg) Decomposition temperature:
Conductivity: Electrochemical window:
Viscosity: 346cp Density:

 
Our company has been engaged in the R&D, production of ionic liquids and related technologies for more than ten years. Since 2007, our company has supplied ionic liquid reagents to customers, and can provide customers with ionic liquid products from grams to hundreds of tons. The main product series are: Imidazolium ionic liquids, single-substituted Im ionic liquids, Disubstituted Im ionic liquids, Tri-Substituted Im ionic liquids, Pyrilidinium ionic liquids, Ammonium ionic liquids, Phosphonium ionic liquids, Pyrrolidinium ionic liquids, Piperidinium ionic liquids, Functionized ionic liquids, Vinyl-Based ionic liquids, Hydroxyl-Based ionic liquids, Ether-Based ionic liquids, Ester-Based ionic liquids, Carboxyl-Based ionic liquids, Nitrile-Based ionic liquids, Amido-Based ionic liquids, SulfoAcid-Based ionic liquids, Benzyl-Based ionic liquids, Guanidine-Based ionic liquids, Oxonium salts
Tetrabutylphosphonium bis(trifluoromethyl sulfonyl)imide


Related News: AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.3-Hydroxy-2-nitropyridine CAS:15128-82-2 Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities.(2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid CAS:361442-00-4 It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.2,2-dimetil-6-nitro-4H-pirido [3,2-b] [1,4] oxazin-3-ona CAS:1002726-59-1 American Airlines and Delta Air Lines announced more flight cancellations to China on Saturday as coronavirus cases continued to rise.ICIG companies currently employ more than 3,000 people and operate 15 manufacturing facilities in Europe and the United States.

Related Products
Product Name
N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1,4-diamine View Details
3,6-Dichloropyridazine View Details
3-chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]aniline View Details
Dicaprylin Cas:36354-80-0 manufacturer 3-Chloro-4-methoxybenzoic Acid manufacturer Methyl (3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidenehexanoate manufacturer 4-Bromo-2-chlorophenol manufacturer Methyl isobutyryl acetate manufacturer